UTMD (STOCKS)
Utah Medical Products Inc
$69.870000
+2.030000 (+2.99%)
Prev close: $67.840000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Kevin Leighton Cornwell
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $222.47M
- Employees
- 167
- P/E (TTM)
- 20.08
- P/B (TTM)
- 1.79
- Dividend Yield
- 181.31%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2024 (Q1)
|
$1.09 | $0.00 | +0.0000 | +0.00% |
|
Jun 2023 (Q2)
|
$1.15 | $0.00 | +0.0000 | +0.00% |
|
Dec 2022 (Q4)
|
$1.25 | $0.00 | +0.0000 | +0.00% |
|
Mar 2014 (Q1)
|
$0.72 | $0.81 | -0.0858 | -10.65% |
Financial Statements
| Revenues | $37.53M |
| Benefits Costs and Expenses | $26.11M |
| Cost Of Revenue | $15.79M |
| Costs And Expenses | $26.11M |
| Gross Profit | $21.75M |
| Operating Expenses | $10.81M |
| Research and Development | $668.00K |
| Operating Income/Loss | $10.94M |
| Income/Loss From Continuing Operations After Tax | $10.85M |
| Income/Loss From Continuing Operations Before Tax | $12.89M |
| Income Tax Expense/Benefit | $2.58M |
| Income Tax Expense/Benefit, Deferred | -$562.00K |
| Net Income/Loss | $10.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $10.85M |
| Net Income/Loss Available To Common Stockholders, Basic | $10.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.38 |
| Diluted Earnings Per Share | $3.38 |
| Basic Average Shares | 9,624,000 |
| Diluted Average Shares | 9,624,000 |
| Assets | $124.38M |
| Current Assets | $100.38M |
| Inventory | $8.72M |
| Other Current Assets | $91.66M |
| Noncurrent Assets | $24.00M |
| Fixed Assets | $9.72M |
| Intangible Assets | $364.00K |
| Other Non-current Assets | $13.92M |
| Liabilities | $4.01M |
| Current Liabilities | $3.51M |
| Accounts Payable | $1.19M |
| Other Current Liabilities | $2.31M |
| Noncurrent Liabilities | $504.00K |
| Equity | $120.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $120.37M |
| Liabilities And Equity | $124.38M |
| Net Cash Flow From Operating Activities | $13.34M |
| Net Cash Flow From Operating Activities, Continuing | $13.34M |
| Net Cash Flow From Investing Activities | -$317.00K |
| Net Cash Flow From Investing Activities, Continuing | -$317.00K |
| Net Cash Flow From Financing Activities | -$9.22M |
| Net Cash Flow From Financing Activities, Continuing | -$9.22M |
| Exchange Gains/Losses | $278.00K |
| Net Cash Flow | $4.08M |
| Net Cash Flow, Continuing | $3.80M |
| Comprehensive Income/Loss | $10.35M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $11.80M |
| Other Comprehensive Income/Loss | -$503.00K |